Koji Yamanoi

38PUBLICATIONS
80CO-AUTHORS
Predictive and prognostic markersReproductionCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Surgery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (38)

|May 22, 2026
Distinct clinical and prognostic features of cervical adenosquamous carcinoma: a nationwide registry-based and propensity score-matched analysis.

|Apr 28, 2026
Long-Term Psychosocial Outcomes in Japanese Mayer-Rokitansky-Küster-Hauser Syndrome: A Single-Center Study.

|Mar 12, 2026
A novel CDK12 inhibitor induces homologous recombination deficiency to enhance PARP inhibitor efficacy in uterine serous carcinoma.

Shunsuke Kawahara, Mana Taki, Junzo Hamanishi

|Jan 27, 2026
HIF2A as a prognostic and clinical therapeutic target in ovarian clear cell carcinoma.

Mengxin Jiang, Ken Yamaguchi, Kohei Hamada

|Jan 14, 2026
Live Birth Outcomes After Extended or Repeated High-Dose Medroxyprogesterone Acetate Therapy for Fertility-Sparing Management of Endometrial Neoplasia: A Single-Center Retrospective Case Series.

Akitoshi Yamamura, Asuka Okunomiya, Akihiro Yanai

|Nov 26, 2025
Real-world multicenter study of immune checkpoint inhibitors in advanced cervical cancer across HPV-associated and HPV-independent subtypes.

Kazuhiro Ko, Mayu Fukuda, Koji Yamanoi

Pageof 7

Frequent Collaborators

17 joint publications

Masaki Mandai

16 joint publications

Ken Yamaguchi

13 joint publications

Mana Taki

9 joint publications

Junzo Hamanishi